The updated vaccine will be available for eligible groups as part of the NHS autumn vaccination program, and will also be available to purchase privately in the UK for the first time CAMBRIDGE, MA / ...

Telluride: Trey Parker and Matt Stone lampooned Casa Bonita with predictable cynicism on "South Park," but their loving odyssey to bring it back to life makes for a charming new documentary.

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on their shots, though all drugmakers say their shots will be ...

MRNA-1403 is under clinical development by Moderna and currently in Phase II for Norovirus Infections. According to GlobalData, Phase II drugs for Norovirus Infections does not have sufficient ...

MRNA-1608 is under clinical development by Moderna and currently in Phase II for Genital Herpes. According to GlobalData, Phase II drugs for Genital Herpes have a 30% phase transition success rate ...

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...

Over the past year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually ...

The mRNA COVID-19 vaccines are manufactured by Pfizer-BioNTech and Moderna, who plan to have them available in a few days. The formula will "more closely target currently circulating variants and ...

Beaumont — Southeast Texans who love Casa Olé now have only one location they can enjoy in Beaumont. The Interstate 10 North location, located near Calder, closed Friday after four decades of serving ...

As of now, two new vaccines have been approved: one from Pfizer/BioNTech and one from Moderna. An update from Novavax is still awaiting approval. The CDC recommends that everyone age 6 months and ...

The FDA has authorized the use of new vaccines from Pfizer/BioNTech and Moderna which have been designed to defend against the Omicron KP.2 variant of SARS-CoV-2. The nod comes as word of a new ...